SRXH ▲ +5.4% - SRX Global Inc.
$SRXH - SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies
07-OCT-2026 03:00 PM ET
Share this post
More filings for $SRXH
SRXH ▲ +1.3% - SRX Global Inc.Oct 6, 2026SRXH ▲ +3.0% - SRX Global Inc.Sep 24, 2026SRXH ▼ -3.4% - SRX Global Inc.Sep 23, 2026SRXH ▼ -0.6% - SRX Global Inc.Aug 31, 2026$SRXH SEC Filing Update (08-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 9, 2026$SRXH SEC Filing Update (25-JUN-2026) | ThinkSabio - Stocks SimplifiedJun 25, 2026
View full $SRXH filing history →💬 Comments
Loading comments…
Leave a comment